the aid library

LIST OPTIONS

Filter

12381

What is Leishmaniasis?

Cafasso, J. Healthline (2018) CC

Leishmaniasis is a parasitic disease caused by the Leishmania parasite. This parasite typically lives in infected sand flies. You can contract leishmaniasis from a bite of an infected sand fly. The sand flies that carry the parasite typically reside in tropical and subtropical environments. Fatal... more

External Link

Echinococcosis Video

Air to air (2022) CC

A parasitic disease caused by the larval stage of tapeworms in the Echinococcus. The disease often starts without symptoms and this may last for years. The symptoms depend on the cyst's location and size. Alveolar disease usually begins in the liver, but can spread to other parts of the body, such... more

External Link

Cutaneous Leishmaniasis: Urgent need to develop more effective and user-friendly point-of-care diagnostic tools

DNDi redeLEISH (2022) CC

Leishmaniasis is a complex vector-borne disease involving in its transmission several species of protozoan parasites called Leishmania, a wide variety of animal reservoirs and phlebotomine sandflies vectors. Cutaneous Leishmaniasis (CL) is the most common form of the disease, and its clinical manife... more

External Link

National Guidline on Management of Leptospirosis

Epidemiology Unit Ministry of Health, Nutrition and Indigenous Medicine Sri Lanka (2016) CC

Leptospirosis is a zoonotic illness with a global disease burden impacting both developed and developing nations. It is caused by pathogenic spirochetes of the genus Leptospira. The pathogenic L.interrogans has more than 250 serovars arranged in 25 serogroups. In Sri Lanka, suspected leptospirosi... more

External Link

Mycetoma: New hope for neglected patients?

Drugs for Neglected Diseases initiative DNDi (2019) CC

Mycetoma is a slow-growing bacterial or fungal infection, most often of the foot, that may spread to other parts of the body and can cause severe deformity. It is a debilitating disease that most often affects poor people in rural areas with limited access to health care.

External Link

Mycetoma, chromoblastomycosis and other deep mycoses

World Health Organization WHO (2023) C_WHO

Mycetoma is a chronic, progressively destructive morbid inflammatory disease usually of the foot but any part of the body can be affected. Infection is most probably acquired by traumatic inoculation of certain fungi or ‎bacteria into the subcutaneous tissue. Mycetoma was described in the modern l... more

External Link

Abaout Scabies

Scotland's national health information service NHS (2023) CC

Scabies is a contagious skin condition caused by tiny mites that burrow into the skin. The main symptom of scabies is intense itching that's worse at night. It also causes a skin rash on areas where the mites have burrowed.

External Link

Buruli Ulcer – Recognize – A guide for field health workers

World Health Organization WHO (2011) C_WHO

The purpose of this document is to contribute to improved recognition of Buruli ulcer (Mycobacterium ulcerans infection) and encourage greater efforts in detecting cases at an early stage of infection.Today, patients can be cured with antibiotics if diagnosed early, thus avoiding unnecessary suff... more

External Link

Global snakebite burden Report by the Director-General

World Health Organization WHO (2018) C_WHO

Snakebite envenoming is a potentially life-threatening disease that typically results from the injection of a mixture of different toxins (“venom”) following the bite of a venomous snake. Envenoming can also be caused by venom being sprayed into a person’s eyes by certain species of snakes tha... more

External Link

Preventable Epilepsy: Taenia Solium Infection Burdens Economies, Societies and Individuals

World Health Organization WHO (2016) C_WHO

Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, health costs and social stigmatization of sufferers. ... more

External Link

WHO Guide for Rabies Pre and Post Exposure Prophylaxis in Humans

World Health Organization WHO (2014) C_WHO

WHO strongly recommends discontinuation of the nerve tissue vaccine, and replacement with modern concentrated and purified cell culture derived vaccines (CCDV) and embryonated eggbased rabies vaccines. These vaccines must comply with WHO criteria for potency and innocuity following satisfactory ass... more

An open label, block randomized, community study of the safety and efficacy of coadministered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic fila

JambulingamI P. , KuttiattI V.S., Krishnamoorthy K. et al (2021) C2

Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) or DA (diethylcarbamazine and ... more

External Link

Guide for the Medical, Veterinary and allied Professions

Bishop, G.; Durrheim, D.; Kloeck, P. et al. Department: Agriculture, Foresty and Fisheries - Republic of South Africa (2010) CC

Rabies is a disease of animals but too often the outcome is gauged in terms of human suffering and death. Despite this, in areas of the world where rabies is endemic there is often a lack of communication between veterinary and medical professionals, to the extent that the disease continues to thri... more

External Link

Towards new generation treatments for leishmaniasis

Drugs for Neglected Diseases initiative DNDi (2019) CC

1 billion people are at risk of infection with leishmaniasis, a neglected disease strongly linked to poverty. There’s no single, simple cure: current treatments are complex and need to be adapted to the form of the disease and geographical region.